People with Metabolic-associated Fatty Liver Disease Had Higher Levels of Blood Insulin after Eating than Comparable Controls
American Physiological Society (APS)
Interdisciplinary researchers in Illinois, the U.S. and around the world can advance their projects with the Beckman Institute for Advanced Science and Technology's new Zeiss Xradia 630 Versa micro-CT scanner, the first of its kind with life science applications in the U.S.
In a new study, Saint Louis University School of Medicine researchers and colleagues have identified biomarkers in high-risk infants with alpha-1 antitrypsin deficiency (AATD). This is a condition that is life-threatening in some infants but very mild in others. For the first time, predicting which children need lifesaving intervention is possible.
As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children’s Hospital of Philadelphia (CHOP) used state-of-the-art technologies to understand the underlying biology of Fontan-associated liver disease (FALD).
Hackensack Meridian Jersey Shore University Medical Center welcomed Lee F. Peng, M.D., PhD, as section chief of gastroenterology, department of medicine.
Resmetirom (Rezdiffra) is the first drug approved for treating MASH, an advanced form of fatty liver disease. UChicago Medicine experts contributed to a recent clinical trial and will begin incorporating the drug into liver disease treatment regimens for eligible patients.
Patients diagnosed with steatotic liver disease (formerly called fatty liver disease) are usually advised to stop drinking alcoholic beverages. But a new study led by Cedars-Sinai found that drinking, on average, a small amount of alcohol a day did not lead to further liver damage in patients with mild disease.
A world-first analysis of a sudden global outbreak of hepatitis in children finds although the primary suspect is highly likely to be an infection by multiple viruses, many questions still puzzle researchers.
Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.
Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.
The Mount Sinai Recanati/Miller Transplantation Institute has received a $5 million gift from the Blavatnik Family Foundation, pledged across five years.
Chula researchers have developed a remarkable wireless hepatitis B virus test kit to screen for infection and collect data for an online database that’s fast and complete in one step.
MIT engineers have developed a small ultrasound sticker that can monitor the stiffness of organs deep inside the body.
A modeling study projecting the economic and social burden of alcohol-associated liver disease by 2040 is featured in the February 2024 issue of AJG, just one month after the new ACG Clinical Guideline on Alcohol-Associated Liver Disease
Males born to obese women are more likely to be overweight at birth and develop metabolic complications in later life, including liver disease and diabetes.
UChicago Medicine was the first hospital in Illinois to treat patients using histotripsy, a new noninvasive technology that uses ultrasound energy to precisely destroy liver tumors.
The Cedars-Sinai Comprehensive Transplant Center and Smidt Heart Institute together completed 652 solid organ transplants in 2023, far outpacing Cedars-Sinai’s internal record set just one year ago, when surgeons completed 583 transplants.
For 21 years, nurses have consistently been the most trusted profession, according to the yearly Gallup poll. (The new poll will be issued by the end of January). Dr Rushton, who specializes in burnout, will speak on trust, moral injury, and how nurses cope in this day and age.
The Vanderbilt Transplant Center (VTC) established a new record in calendar year 2023 for total solid organ transplants, performing 739 lifesaving procedures among its adult and pediatric organ transplant programs.
Chirag Desai, MD, FACS, an abdominal organ transplant and hepatobiliary-pancreatic surgeon at UNC Hospitals, performed a “domino” liver transplant, which helped two patients from a single donor without splitting a liver.
The latest research and expertise on the flue can be found in the Influenza channel on Newswise.
Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, together with RWJBarnabas Health, has joined a select number of institutions nationwide that offer a specialized chemotherapy delivery system called hepatic artery infusion (HAI) therapy for patients with liver tumors.
Noninvasive non-alcoholic steatohepatitis (NASH) assessment is a clinical challenge in managing non-alcoholic fatty liver disease.
Investigators from the Smidt Heart Institute at Cedars-Sinai and colleagues found that women with fatty liver disease related to alcohol consumption have almost twice the risk of dying within a certain time period than men with the same condition.
Metabolic dysfunction–associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis) is an inflammatory, liver-scarring disease that affects 1.5% to 6.5% of all U.S. adults.
A roundup of 2023 medical discoveries and innovations at Cedars-Sinai Cancer.
Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.
RUDN University biologists and colleagues from Jordan and Malaysia found that a flavonoid from green tea mitigates the harmful effects of hookah smoking - it reduces inflammation and oxidative stress while protecting the tissues of the lungs, liver, and kidneys.
The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of the disease.
Among the accomplishments of this year’s awardees are discoveries related to the role of altered pharmacokinetics in non-alcoholic fatty liver disease, the mechanisms of Parkinson’s disease neurodegeneration, the risk of COVID-19 to smokers and vapers, and the role of the microbiome in pregnancy and early developmental programming.
A new ACG Clinical Guideline on alcohol-associated liver disease (ALD) is featured in the January 2024 issue of The American Journal of Gastroenterology.
Hepatitis linked to alcohol, the most severe form of alcohol-associated liver disease, is increasingly prevalent, severe, and likely to involve emergency departments, according to a new analysis.
The gut microbiome, consisting of trillions of bacteria, viruses, and fungi, plays a crucial role in digestion, nutrient absorption, and the regulation of host metabolism and immunity.
Children’s Hospital Los Angeles has performed its 500th liver transplant—a milestone achievement that only a handful of pediatric centers in the country have reached.
With the rise in machine learning applications and artificial intelligence, it's no wonder that more and more scientists and researchers are turning to supercomputers. Supercomputers are commonly used for making predictions with advanced modeling and simulations. This can be applied to climate research, weather forecasting, genomic sequencing, space exploration, aviation engineering and more.
The December 2023 issue of ToxSci features a Contemporary Review exploring lipid mediator–driven inflammation following air pollution exposure, an In-Depth Review on the state of in vitro skin models, and ToxSpotlights on the effects of inhalation exposure to TCE and the dose-response assessment of non-mutagenic liver carcinogens.
Researchers at UChicago were able to predict postoperative infections in liver transplant patients by analyzing molecules in their poop — a key leap forward in exploring the connection between the gut microbiome and overall health.
SARS-CoV-2 persists in the respiratory tract, notably in patients with underlying co-morbidities including liver disease.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
Cedars-Sinai investigators have discovered how the liver defends itself against cancer. Their study, published in the peer-reviewed Journal of Hepatology, suggests targets for therapies to protect the liver both from cancers that originate there and cancers that spread to the liver from other parts of the body.
In the December issue of AJG: assisted reproductive technology among women with liver disease, strategies for incorporating sexual and gender minorities in GI research, anxiety/depression in GERD patients, and more.
This Thanksgiving marks a little more than 25 years since Christine Galan became the first person in the Western U.S. to have a combined organ transplant (heart and liver), and nearly five years since she returned to Cedars-Sinai for another organ transplant—this time, a kidney.
Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.
Researchers at the Research Institute of Molecular and Cellular Medicine of RUDN University have found that with significant damage to the liver, the spleen begins to actively help its neighbor in the abdominal cavity. It shares immune cells and triggers anti-inflammatory processes.
The former Metabolic and Fatty Liver Clinic at the University of Chicago Medicine is undergoing a name change, as part of a shift in language to drop stigmatizing words, precisely describe the condition and identify a subgroup of patients omitted under the former diagnostic criteria.
In a groundbreaking achievement for cancer treatment, research, and medical technology, the U.S. Food and Drug Administration (FDA) has granted approval for the HistoSonics’ Edison histotripsy device to treat liver tumors.
A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved medications.
Researchers at University of California San Diego have discovered a process in which liver cells share molecules in order to multiply under conditions that would ordinarily suppress cell proliferation. They also found evidence that this process occurs in various types of cancer cells.